GYNECURE TANDEMPK.VAG OV.300MG/VULV.CRM1%W/W
GYNECURE TANDEMPK.VAG OV.300MG/VULV.CRM1%W/W
Discontinued
DIN Number
02218283
Drug Class
Human
Market Date
Dec 2, 1996
Company
HC
pfizer canada inc., consumer healthcare division
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02218283
AIG Number0236810004
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
G01AF08 TIOCONAZOLE
Product Specifications
Dosage FormCream
,
Suppository
Route of AdministrationVaginal
,
Topical
AHFS Classification84:04.08.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
TIOCONAZOLEActive
Strength: 1 % / KIT
Monograph: TIOCONAZOLE
TIOCONAZOLEActive
Strength: 300 MG / KIT
Monograph: TIOCONAZOLE